Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

CONTEXT: Current osteoporosis medications increase bone mineral density (BMD) modestly and reduce, but do not eliminate, fracture risk. Attempts to improve efficacy by administering anabolic agents and bisphosphonates concomitantly have been unsuccessful. Conversely, 12 months of concomitant denosum...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Burnett-Bowie, Sherri-Ann M., Zhu, Yuli, Foley, Katelyn, Lee, Hang, Neer, Robert M.
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2014
Teme:
Endocrine Care
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010689/
https://ncbi.nlm.nih.gov/pubmed/24517156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-4440
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items